智通财经APP讯，同仁堂科技(01666)发布截至2025年6月30日止6个月中期业绩，该集团取得收入人民币37.39亿元(单位下同)，同比减少7.69%;公司所有者应占净利润3.39亿元，同比减少21.01%;每股基本收益0.26元。
公告称，销售收入及净利润减少主要由于营销改革深入推进，加速市场库存周转，优化库存结构，市场秩序逐步向好，随着改革的推进，经营质量将稳步提升，为持续高质量发展奠定坚实基础。
于报告期内，集团销售额超过人民币1亿元的产品4个;销售额介于人民币1000万元至人民币1亿元之间的产品28个;销售额介于人民币500万元至人民币1000万元之间的产品10个。主导产品中，六味地黄丸系列销售收入较上年同期增长约47.99%、金匮肾气系列销售收入较上年同期增长约19.55%，京制牛黄解毒片系列销售收入较上年同期增长约4.03%，感冒清热颗粒系列及生脉饮口服液系列销售收入较上年同期有所下降。但受益于“大品种战略”，壮腰健肾丸系列、知柏地黄丸系列及归芍地黄丸系列等产品的销售收入均较上年同期实现双位数增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.